RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $0 | −100.0% |
| Operating income | −$1.6B | — |
| Net income | −$1.8B | — |
| EPS | −$8.84 | — |
| Free cash flow | −$1.2B | — |
Revolution Medicines, Inc.
$205.26+0.78 (+0.38%)Close Sep 30, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $0 | −100.0% |
| Operating income | −$1.6B | — |
| Net income | −$1.8B | — |
| EPS | −$8.84 | — |
| Free cash flow | −$1.2B | — |